Ono Pharmaceutical Co., Ltd.
Stock Forecast, Prediction & Price Target
Ono Pharmaceutical Co., Ltd. Financial Estimates
Ono Pharmaceutical Co., Ltd. Revenue Estimates
Ono Pharmaceutical Co., Ltd. EBITDA Estimates
Ono Pharmaceutical Co., Ltd. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2022 | 3/31/2023 | 3/31/2024 | 3/31/2026 | 3/31/2027 | 3/31/2028 | 3/31/2029 |
Revenue
% change YoY
| $361.36B N/A | $447.18B 23.75% | $502.67B 12.40% | Avg: $462.09B Low: $462.09B High: $462.09B avg. -8.07% | Avg: $467.27B Low: $467.27B High: $467.27B avg. 1.11% | Avg: $450.27B Low: $450.27B High: $450.27B avg. -3.63% | Avg: $444.92B Low: $444.92B High: $444.92B avg. -1.18% |
Net Income
% change YoY
| $80.51B N/A | $112.72B 39.99% | $127.97B 13.53% | Avg: $33.59B Low: $33.59B High: $33.59B avg. -73.74% | Avg: $35.60B Low: $35.60B High: $35.60B avg. 5.96% | Avg: $32.43B Low: $32.43B High: $32.43B avg. -8.89% | Avg: $32.78B Low: $32.78B High: $32.78B avg. 1.07% |
EBITDA
% change YoY
| $123.62B N/A | $167.49B 35.49% | $178.43B 6.53% | Avg: $163.26B Low: $163.26B High: $163.26B avg. -8.50% | Avg: $165.08B Low: $165.08B High: $165.08B avg. 1.11% | Avg: $159.08B Low: $159.08B High: $159.08B avg. -3.63% | Avg: $157.19B Low: $157.19B High: $157.19B avg. -1.18% |
EPS
% change YoY
| $54.06 N/A | $76.94 42.32% | $266.57 246.46% | Avg: $69.99 Low: $69.99 High: $69.99 avg. -73.74% | Avg: $74.16 Low: $74.16 High: $74.16 avg. 5.96% | Avg: $67.57 Low: $67.57 High: $67.57 avg. -8.89% | Avg: $68.3 Low: $68.3 High: $68.3 avg. 1.07% |
Operating Expenses
% change YoY
| $164.65B N/A | $195.16B 18.52% | $212.44B 8.85% | Avg: $98.71B Low: $98.71B High: $98.71B avg. -53.53% | Avg: $99.81B Low: $99.81B High: $99.81B avg. 1.11% | Avg: $96.18B Low: $96.18B High: $96.18B avg. -3.63% | Avg: $95.04B Low: $95.04B High: $95.04B avg. -1.18% |
FAQ
What is Ono Pharmaceutical Co., Ltd. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -18.90% in 2026-2029.
We have gathered data from N/A analysts. Their low estimate is 33.59B, average is 33.59B and high is 33.59B.
What is Ono Pharmaceutical Co., Ltd. stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -2.94% in 2026-2029.
We have gathered data from N/A analysts. Their low revenue estimate is $462.09B, average is $462.09B and high is $462.09B.
What is Ono Pharmaceutical Co., Ltd. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -18.89% in 2026-2029.
We have gathered data from N/A analysts. Their low earnings per share estimate is $69.99, average is $69.99 and high is $69.99.